TITLE

Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base

AUTHOR(S)
Aledort, Julia E.; Lurie, Nicole; Wasserman, Jeffrey; Bozzette, Samuel A.
PUB. DATE
January 2007
SOURCE
BMC Public Health;2007, Vol. 7, p208
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In an influenza pandemic, the benefit of vaccines and antiviral medications will be constrained by limitations on supplies and effectiveness. Non-pharmaceutical public health interventions will therefore be vital in curtailing disease spread. However, the most comprehensive assessments of the literature to date recognize the generally poor quality of evidence on which to base non-pharmaceutical pandemic planning decisions. In light of the need to prepare for a possible pandemic despite concerns about the poor quality of the literature, combining available evidence with expert opinion about the relative merits of non-pharmaceutical interventions for pandemic influenza may lead to a more informed and widely accepted set of recommendations. We evaluated the evidence base for non-pharmaceutical public health interventions. Then, based on the collective evidence, we identified a set of recommendations for and against interventions that are specific to both the setting in which an intervention may be used and the pandemic phase, and which can be used by policymakers to prepare for a pandemic until scientific evidence can definitively respond to planners' needs. Methods: Building on reviews of past pandemics and recent historical inquiries, we evaluated the relative merits of non-pharmaceutical interventions by combining available evidence from the literature with qualitative and quantitative expert opinion. Specifically, we reviewed the recent scientific literature regarding the prevention of human-to-human transmission of pandemic influenza, convened a meeting of experts from multiple disciplines, and elicited expert recommendation about the use of non-pharmaceutical public health interventions in a variety of settings (healthcare facilities; community-based institutions; private households) and pandemic phases (no pandemic; no US pandemic; early localized US pandemic; advanced US pandemic). Results: The literature contained a dearth of evidence on the efficacy or effectiveness of most non-pharmaceutical interventions for influenza. In an effort to inform decision-making in the absence of strong scientific evidence, the experts ultimately endorsed hand hygiene and respiratory etiquette, surveillance and case reporting, and rapid viral diagnosis in all settings and during all pandemic phases. They also encouraged patient and provider use of masks and other personal protective equipment as well as voluntary self-isolation of patients during all pandemic phases. Other non-pharmaceutical interventions including mask-use and other personal protective equipment for the general public, school and workplace closures early in an epidemic, and mandatory travel restrictions were rejected as likely to be ineffective, infeasible, or unacceptable to the public. Conclusion: The demand for scientific evidence on non-pharmaceutical public health interventions for influenza is pervasive, and present policy recommendations must rely heavily on expert judgment. In the absence of a definitive science base, our assessment of the evidence identified areas for further investigation as well as non-pharmaceutical public health interventions that experts believe are likely to be beneficial, feasible and widely acceptable in an influenza pandemic.
ACCESSION #
29362082

 

Related Articles

  • Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions. Duerr, Hans P.; Brockmann, Stefan O.; Piechotowski, Isolde; Schwehm, Markus; Eichner, Martin // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p1 

    Background: Influenza pandemic preparedness plans are currently developed and refined on national and international levels. Much attention has been given to the administration of antiviral drugs, but contact reduction can also be an effective part of mitigation strategies and has the advantage...

  • Review: Vaccination reduces the incidence of serologically confirmed influenza in healthy adults: COMMENTARY. Sacks, Henry S. // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p70 

    In this article the author reports that influenza is a complicated public health problem. Both the antigenic makeup of the virus and the number of new cases can vary greatly from year to year, and the demand for the vaccine is also unpredictable. In a bad year, influenza can cause thousands of...

  • Pandemic Pandemonium. Ruxin, Josh N. // National Interest;Jul/Aug2008, Issue 96, p26 

    The article offers the author's views on preventing a global health pandemic. He believes that rich nations should strengthen the health systems for the poor because new diseases and the resurgence of old ones are likely to emerge where people are sickest or have inconsistent treatment. The...

  • INTRICACIES OF NEWLY EMERGED SWINE FLU PANDEMIC: A GLOBAL ENVIRONMENTAL, MEDICAL AND PUBLIC HEALTH CHALLENGE-SHOULD THE NIGERIA BE ALARMED? Okonko, I. O.; Onoja, B. A.; Udueze, A. O.; Adedeji, A. O.; Motayo, O. B.; Akanbi, O. A.; Ogun, A. A. // Electronic Journal of Environmental, Agricultural & Food Chemist;Mar2010, Vol. 9 Issue 3, p533 

    This review article reports on the newly emerged swine influenza pandemic: a global environemental, medical and public health challenge-should the Nigeria be alarmed? It also examines the features of H1N1, including incidence, infection, immunity, clinical management, prevention and control, and...

  • 2009 H1N1 Influenza. Sullivan, Seth J.; Jacobson, Robert M.; Dowdle, Walter R.; Poland, Gregory A. // Mayo Clinic Proceedings;Jan2010, Vol. 85 Issue 1, p64 

    Within 2 months of its discovery last spring, a novel influenza A (H1N1) virus, currently referred to as 2009 H1N1, caused the first influenza pandemic in decades. The virus has caused disproportionate disease among young people with early reports of virulence similar to that of seasonal...

  • Pandemic Influenza's 500th Anniversary. Morens, David M.; Taubenberger, Jeffery K.; Folkers, Gregory K.; Fauci, Anthony S. // Clinical Infectious Diseases;12/15/2010, Vol. 51 Issue 12, p1442 

    It is impossible to know with certainty the first time that an influenza virus infected humans or when the first influenza pandemic occurred. However, many historians agree that the year 1510 A.D.-500 years ago-marks the first recognition of pandemic influenza. On this significant anniversary it...

  • The invention of the swine-flu pandemic. Keil, Ulrich; Schönhöfer, Peter; Spelsberg, Angela // European Journal of Epidemiology; 

    No abstract available.

  • Finding the real case-fatality rate of H5N1 avian influenza. Li, F. C. K.; Choi, B. C. K.; Sly, T.; Pak, A. W. P. // Journal of Epidemiology & Community Health;Jun2008, Vol. 62 Issue 6, p555 

    Background: Accurate estimation of the case-fatality (CF) rate, or the proportion of cases that die, is central to pandemic planning. While estimates of CF rates for past influenza pandemics have ranged from about 0.1% (1957 and 1968 pandemics) to 2.5% (1918 pandemic), the official World Health...

  • Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options. Maltezou, Helen C.; Tsiodras, Sotirios // Current Drug Targets;Oct2009, Vol. 10 Issue 10, p1041 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics